Registration
TAYLOR, SYLLA & AGIN, LLP for FIGHT TO LIVE
Client
Income
—
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Patient Choice Act of 2013, FDA provisional approval for drugs with adequate safety profiles.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JONATHAN ERIC AGIN New | — |
Medical/Disease Research/Clinical Labs MED
Patient Choice Act of 2013, FDA provisional approval for drugs with adequate safety profiles.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JONATHAN ERIC AGIN New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.